These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29191372)

  • 1. Th1-related disease development during omalizumab treatment: Two cases with severe asthma.
    Hayashi H; Fukutomi Y; Mitsui C; Watai K; Tomita Y; Kamide Y; Sekiya K; Tsuburai T; Horita A; Saito I; Hasegawa Y; Taniguchi M
    Allergol Int; 2018 Jul; 67(3):405-407. PubMed ID: 29191372
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma.
    Tajiri T; Matsumoto H; Gon Y; Ito R; Hashimoto S; Izuhara K; Suzukawa M; Ohta K; Ono J; Ohta S; Ito I; Oguma T; Inoue H; Iwata T; Kanemitsu Y; Nagasaki T; Niimi A; Mishima M
    Allergy; 2016 Oct; 71(10):1472-9. PubMed ID: 27113353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of upper and lower airway eosinophilic inflammation with response to omalizumab in patients with severe asthma.
    Kurokawa M; Koya T; Takeuchi H; Hayashi M; Sakagami T; Ishioka K; Gon Y; Hasegawa T; Kikuchi T
    J Asthma; 2020 Jan; 57(1):71-78. PubMed ID: 30489179
    [No Abstract]   [Full Text] [Related]  

  • 4. Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma.
    Sposato B; Scalese M; Milanese M; Masieri S; Cavaliere C; Latorre M; Scichilone N; Matucci A; Vultaggio A; Ricci A; Cresti A; Paggiaro PL
    J Investig Allergol Clin Immunol; 2017; 27(6):388-391. PubMed ID: 29199967
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma.
    Busse WW; Humbert M; Haselkorn T; Ortiz B; Trzaskoma BL; Stephenson P; Garcia Conde L; Kianifard F; Holgate ST
    Ann Allergy Asthma Immunol; 2020 Feb; 124(2):190-196. PubMed ID: 31760132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab effectively protects against early and late allergic responses in asthma after 4 weeks.
    Trischler J; Lieb A; Arnold M; Schulze J; Rosewich M; Schubert R; Bottoli I; Zielen S
    Allergy; 2017 Dec; 72(12):1912-1915. PubMed ID: 28581121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab in severe asthma: Evaluation of the clinical impact after its withdrawal.
    D de Sousa M; Ferreira C; Arrobas A
    Rev Port Pneumol (2006); 2017; 23(2):108-109. PubMed ID: 28209342
    [No Abstract]   [Full Text] [Related]  

  • 8. Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study.
    Deschildre A; Roussel J; Drumez E; Abou-Taam R; Rames C; Le Roux P; Pouessel G; Scalbert M; Bonnel C; Mitha S; Boileau S; Mordacq C; Thumerelle C; Labreuche J; Lejeune S; Marguet C
    Allergy; 2019 May; 74(5):999-1003. PubMed ID: 30481388
    [No Abstract]   [Full Text] [Related]  

  • 9. Does omalizumab impair glucose homeostasis in a patient with severe persistent asthma and type 2 diabetes mellitus?
    Hamada S; Kuroe A; Tsukino M
    Rev Port Pneumol (2006); 2017; 23(5):303-304. PubMed ID: 28602732
    [No Abstract]   [Full Text] [Related]  

  • 10. Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy.
    Odajima H; Ebisawa M; Nagakura T; Fujisawa T; Akasawa A; Ito K; Doi S; Yamaguchi K; Katsunuma T; Kurihara K; Kondo N; Sugai K; Nambu M; Hoshioka A; Yoshihara S; Sato N; Seko N; Nishima S
    Allergol Int; 2015 Oct; 64(4):364-70. PubMed ID: 26433533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life long-term omalizumab therapy in children with severe allergic asthma.
    Deschildre A; Marguet C; Langlois C; Pin I; Rittié JL; Derelle J; Abou Taam R; Fayon M; Brouard J; Dubus JC; Siret D; Weiss L; Pouessel G; Beghin L; Just J
    Eur Respir J; 2015 Sep; 46(3):856-9. PubMed ID: 26022964
    [No Abstract]   [Full Text] [Related]  

  • 12. Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study.
    Domingo C; Pomares X; Navarro A; Rudi N; Sogo A; Dávila I; Mirapeix RM
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and development of omalizumab for the treatment of asthma.
    Licari A; Marseglia G; Castagnoli R; Marseglia A; Ciprandi G
    Expert Opin Drug Discov; 2015; 10(9):1033-42. PubMed ID: 25979110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?
    Amat F; Labbé A
    Expert Rev Respir Med; 2018 Jun; 12(6):475-482. PubMed ID: 29741411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab and allergen immunotherapy in a patient with asthma and inhaled corticosteroid-induced adrenal suppression.
    Forbush JT; Banks TA
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):335-7. PubMed ID: 27613470
    [No Abstract]   [Full Text] [Related]  

  • 16. The utility of a multidomain assessment of steroid response for predicting clinical response to omalizumab.
    Fleming L; Koo M; Bossley CJ; Nagakumar P; Bush A; Saglani S
    J Allergy Clin Immunol; 2016 Jul; 138(1):292-294. PubMed ID: 26924468
    [No Abstract]   [Full Text] [Related]  

  • 17. The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study.
    Bhutani M; Yang WH; Hébert J; de Takacsy F; Stril JL
    PLoS One; 2017; 12(8):e0183869. PubMed ID: 28859150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Omalizumab and allergen immunotherapy: A clinical report and review of the literature].
    Carrier C; Demoly P; Caimmi D
    Rev Mal Respir; 2019 Feb; 36(2):191-196. PubMed ID: 30396780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe uncontrolled asthma in patients over 75 years old: Treatment with omalizumab].
    Romand P; Kelkel E; Saint-Raymond C; Glas N; Caillaud D; Devouassoux G
    Rev Mal Respir; 2016 May; 33(5):397-400. PubMed ID: 26346416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation.
    Kantor DB; McDonald MC; Stenquist N; Schultz BJ; Smallwood CD; Nelson KA; Phipatanakul W; Hirschhorn JN
    Am J Respir Crit Care Med; 2016 Dec; 194(12):1552-1555. PubMed ID: 27976938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.